Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...